Interstitial Lung Disease (ILD) Market, Global Outlook and Forecast 2022-2028
Interstitial Lung Disease (ILD), also referred to as pulmonary fibrosis or interstitial pneumonia, comprises a group of conditions characterized by varying degrees of inflammation and scarring around the tiny air sacs (alveoli) in the lungs. Interstitial Lung Disease treatment market in this report.
This report contains market size and forecasts of Interstitial Lung Disease (ILD) in Global, including the following market information:
Global Interstitial Lung Disease (ILD) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Interstitial Lung Disease (ILD) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Interstitial Pneumonia Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Interstitial Lung Disease (ILD) include Boehringer Ingelheim, Bellerophon Therapeutics, Inc, Bayer, Fujirebio (Miraca), Philips, Merck and Siemens Healthineers, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interstitial Lung Disease (ILD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interstitial Lung Disease (ILD) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Interstitial Lung Disease (ILD) Market Segment Percentages, by Type, 2021 (%)
Global Interstitial Lung Disease (ILD) Market Segment Percentages, by Application, 2021 (%)
Global Interstitial Lung Disease (ILD) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Interstitial Lung Disease (ILD) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Interstitial Lung Disease (ILD) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Interstitial Lung Disease (ILD) in Global, including the following market information:
Global Interstitial Lung Disease (ILD) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Interstitial Lung Disease (ILD) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Interstitial Pneumonia Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Interstitial Lung Disease (ILD) include Boehringer Ingelheim, Bellerophon Therapeutics, Inc, Bayer, Fujirebio (Miraca), Philips, Merck and Siemens Healthineers, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interstitial Lung Disease (ILD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interstitial Lung Disease (ILD) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Interstitial Lung Disease (ILD) Market Segment Percentages, by Type, 2021 (%)
- Interstitial Pneumonia
- Idiopathic Pulmonary Fibrosis
- Nonspecific Interstitial Pneumonitis
- Hypersensitivity Pneumonitis
- Cryptogenic Organizing Pneumonia
- Acute Interstitial Pneumonitis
- Desquamative Interstitial Pneumonitis
- Others
Global Interstitial Lung Disease (ILD) Market Segment Percentages, by Application, 2021 (%)
- Adults
- Children
Global Interstitial Lung Disease (ILD) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Interstitial Lung Disease (ILD) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Interstitial Lung Disease (ILD) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Boehringer Ingelheim
- Bellerophon Therapeutics, Inc
- Bayer
- Fujirebio (Miraca)
- Philips
- Merck
- Siemens Healthineers
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Interstitial Lung Disease (ILD) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Interstitial Lung Disease (ILD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INTERSTITIAL LUNG DISEASE (ILD) OVERALL MARKET SIZE
2.1 Global Interstitial Lung Disease (ILD) Market Size: 2021 VS 2028
2.2 Global Interstitial Lung Disease (ILD) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Interstitial Lung Disease (ILD) Players in Global Market
3.2 Top Global Interstitial Lung Disease (ILD) Companies Ranked by Revenue
3.3 Global Interstitial Lung Disease (ILD) Revenue by Companies
3.4 Top 3 and Top 5 Interstitial Lung Disease (ILD) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Interstitial Lung Disease (ILD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Interstitial Lung Disease (ILD) Players in Global Market
3.6.1 List of Global Tier 1 Interstitial Lung Disease (ILD) Companies
3.6.2 List of Global Tier 2 and Tier 3 Interstitial Lung Disease (ILD) Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Interstitial Lung Disease (ILD) Market Size Markets, 2021 & 2028
4.1.2 Interstitial Pneumonia
4.1.3 Idiopathic Pulmonary Fibrosis
4.1.4 Nonspecific Interstitial Pneumonitis
4.1.5 Hypersensitivity Pneumonitis
4.1.6 Cryptogenic Organizing Pneumonia
4.1.7 Acute Interstitial Pneumonitis
4.1.8 Desquamative Interstitial Pneumonitis
4.1.9 Others
4.2 By Type - Global Interstitial Lung Disease (ILD) Revenue & Forecasts
4.2.1 By Type - Global Interstitial Lung Disease (ILD) Revenue, 2017-2022
4.2.2 By Type - Global Interstitial Lung Disease (ILD) Revenue, 2023-2028
4.2.3 By Type - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Interstitial Lung Disease (ILD) Market Size, 2021 & 2028
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Interstitial Lung Disease (ILD) Revenue & Forecasts
5.2.1 By Application - Global Interstitial Lung Disease (ILD) Revenue, 2017-2022
5.2.2 By Application - Global Interstitial Lung Disease (ILD) Revenue, 2023-2028
5.2.3 By Application - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Interstitial Lung Disease (ILD) Market Size, 2021 & 2028
6.2 By Region - Global Interstitial Lung Disease (ILD) Revenue & Forecasts
6.2.1 By Region - Global Interstitial Lung Disease (ILD) Revenue, 2017-2022
6.2.2 By Region - Global Interstitial Lung Disease (ILD) Revenue, 2023-2028
6.2.3 By Region - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Interstitial Lung Disease (ILD) Revenue, 2017-2028
6.3.2 US Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.3.3 Canada Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.3.4 Mexico Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Interstitial Lung Disease (ILD) Revenue, 2017-2028
6.4.2 Germany Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.3 France Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.4 U.K. Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.5 Italy Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.6 Russia Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.7 Nordic Countries Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.8 Benelux Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Interstitial Lung Disease (ILD) Revenue, 2017-2028
6.5.2 China Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.5.3 Japan Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.5.4 South Korea Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.5.5 Southeast Asia Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.5.6 India Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Interstitial Lung Disease (ILD) Revenue, 2017-2028
6.6.2 Brazil Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.6.3 Argentina Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Interstitial Lung Disease (ILD) Revenue, 2017-2028
6.7.2 Turkey Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.7.3 Israel Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.7.4 Saudi Arabia Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.7.5 UAE Interstitial Lung Disease (ILD) Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Corporate Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Interstitial Lung Disease (ILD) Major Product Offerings
7.1.4 Boehringer Ingelheim Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.1.5 Boehringer Ingelheim Key News
7.2 Bellerophon Therapeutics, Inc
7.2.1 Bellerophon Therapeutics, Inc Corporate Summary
7.2.2 Bellerophon Therapeutics, Inc Business Overview
7.2.3 Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Major Product Offerings
7.2.4 Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.2.5 Bellerophon Therapeutics, Inc Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Interstitial Lung Disease (ILD) Major Product Offerings
7.3.4 Bayer Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.3.5 Bayer Key News
7.4 Fujirebio (Miraca)
7.4.1 Fujirebio (Miraca) Corporate Summary
7.4.2 Fujirebio (Miraca) Business Overview
7.4.3 Fujirebio (Miraca) Interstitial Lung Disease (ILD) Major Product Offerings
7.4.4 Fujirebio (Miraca) Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.4.5 Fujirebio (Miraca) Key News
7.5 Philips
7.5.1 Philips Corporate Summary
7.5.2 Philips Business Overview
7.5.3 Philips Interstitial Lung Disease (ILD) Major Product Offerings
7.5.4 Philips Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.5.5 Philips Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Interstitial Lung Disease (ILD) Major Product Offerings
7.6.4 Merck Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.6.5 Merck Key News
7.7 Siemens Healthineers
7.7.1 Siemens Healthineers Corporate Summary
7.7.2 Siemens Healthineers Business Overview
7.7.3 Siemens Healthineers Interstitial Lung Disease (ILD) Major Product Offerings
7.7.4 Siemens Healthineers Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.7.5 Siemens Healthineers Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Interstitial Lung Disease (ILD) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Interstitial Lung Disease (ILD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INTERSTITIAL LUNG DISEASE (ILD) OVERALL MARKET SIZE
2.1 Global Interstitial Lung Disease (ILD) Market Size: 2021 VS 2028
2.2 Global Interstitial Lung Disease (ILD) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Interstitial Lung Disease (ILD) Players in Global Market
3.2 Top Global Interstitial Lung Disease (ILD) Companies Ranked by Revenue
3.3 Global Interstitial Lung Disease (ILD) Revenue by Companies
3.4 Top 3 and Top 5 Interstitial Lung Disease (ILD) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Interstitial Lung Disease (ILD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Interstitial Lung Disease (ILD) Players in Global Market
3.6.1 List of Global Tier 1 Interstitial Lung Disease (ILD) Companies
3.6.2 List of Global Tier 2 and Tier 3 Interstitial Lung Disease (ILD) Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Interstitial Lung Disease (ILD) Market Size Markets, 2021 & 2028
4.1.2 Interstitial Pneumonia
4.1.3 Idiopathic Pulmonary Fibrosis
4.1.4 Nonspecific Interstitial Pneumonitis
4.1.5 Hypersensitivity Pneumonitis
4.1.6 Cryptogenic Organizing Pneumonia
4.1.7 Acute Interstitial Pneumonitis
4.1.8 Desquamative Interstitial Pneumonitis
4.1.9 Others
4.2 By Type - Global Interstitial Lung Disease (ILD) Revenue & Forecasts
4.2.1 By Type - Global Interstitial Lung Disease (ILD) Revenue, 2017-2022
4.2.2 By Type - Global Interstitial Lung Disease (ILD) Revenue, 2023-2028
4.2.3 By Type - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Interstitial Lung Disease (ILD) Market Size, 2021 & 2028
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Interstitial Lung Disease (ILD) Revenue & Forecasts
5.2.1 By Application - Global Interstitial Lung Disease (ILD) Revenue, 2017-2022
5.2.2 By Application - Global Interstitial Lung Disease (ILD) Revenue, 2023-2028
5.2.3 By Application - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Interstitial Lung Disease (ILD) Market Size, 2021 & 2028
6.2 By Region - Global Interstitial Lung Disease (ILD) Revenue & Forecasts
6.2.1 By Region - Global Interstitial Lung Disease (ILD) Revenue, 2017-2022
6.2.2 By Region - Global Interstitial Lung Disease (ILD) Revenue, 2023-2028
6.2.3 By Region - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Interstitial Lung Disease (ILD) Revenue, 2017-2028
6.3.2 US Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.3.3 Canada Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.3.4 Mexico Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Interstitial Lung Disease (ILD) Revenue, 2017-2028
6.4.2 Germany Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.3 France Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.4 U.K. Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.5 Italy Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.6 Russia Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.7 Nordic Countries Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.4.8 Benelux Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Interstitial Lung Disease (ILD) Revenue, 2017-2028
6.5.2 China Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.5.3 Japan Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.5.4 South Korea Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.5.5 Southeast Asia Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.5.6 India Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Interstitial Lung Disease (ILD) Revenue, 2017-2028
6.6.2 Brazil Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.6.3 Argentina Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Interstitial Lung Disease (ILD) Revenue, 2017-2028
6.7.2 Turkey Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.7.3 Israel Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.7.4 Saudi Arabia Interstitial Lung Disease (ILD) Market Size, 2017-2028
6.7.5 UAE Interstitial Lung Disease (ILD) Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Corporate Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Interstitial Lung Disease (ILD) Major Product Offerings
7.1.4 Boehringer Ingelheim Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.1.5 Boehringer Ingelheim Key News
7.2 Bellerophon Therapeutics, Inc
7.2.1 Bellerophon Therapeutics, Inc Corporate Summary
7.2.2 Bellerophon Therapeutics, Inc Business Overview
7.2.3 Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Major Product Offerings
7.2.4 Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.2.5 Bellerophon Therapeutics, Inc Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Interstitial Lung Disease (ILD) Major Product Offerings
7.3.4 Bayer Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.3.5 Bayer Key News
7.4 Fujirebio (Miraca)
7.4.1 Fujirebio (Miraca) Corporate Summary
7.4.2 Fujirebio (Miraca) Business Overview
7.4.3 Fujirebio (Miraca) Interstitial Lung Disease (ILD) Major Product Offerings
7.4.4 Fujirebio (Miraca) Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.4.5 Fujirebio (Miraca) Key News
7.5 Philips
7.5.1 Philips Corporate Summary
7.5.2 Philips Business Overview
7.5.3 Philips Interstitial Lung Disease (ILD) Major Product Offerings
7.5.4 Philips Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.5.5 Philips Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Interstitial Lung Disease (ILD) Major Product Offerings
7.6.4 Merck Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.6.5 Merck Key News
7.7 Siemens Healthineers
7.7.1 Siemens Healthineers Corporate Summary
7.7.2 Siemens Healthineers Business Overview
7.7.3 Siemens Healthineers Interstitial Lung Disease (ILD) Major Product Offerings
7.7.4 Siemens Healthineers Interstitial Lung Disease (ILD) Revenue in Global Market (2017-2022)
7.7.5 Siemens Healthineers Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Interstitial Lung Disease (ILD) Market Opportunities & Trends in Global Market
Table 2. Interstitial Lung Disease (ILD) Market Drivers in Global Market
Table 3. Interstitial Lung Disease (ILD) Market Restraints in Global Market
Table 4. Key Players of Interstitial Lung Disease (ILD) in Global Market
Table 5. Top Interstitial Lung Disease (ILD) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Interstitial Lung Disease (ILD) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Interstitial Lung Disease (ILD) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Interstitial Lung Disease (ILD) Product Type
Table 9. List of Global Tier 1 Interstitial Lung Disease (ILD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Interstitial Lung Disease (ILD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Interstitial Lung Disease (ILD) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Interstitial Lung Disease (ILD) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Interstitial Lung Disease (ILD) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Interstitial Lung Disease (ILD) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Interstitial Lung Disease (ILD) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Interstitial Lung Disease (ILD) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2023-2028
Table 30. Boehringer Ingelheim Corporate Summary
Table 31. Boehringer Ingelheim Interstitial Lung Disease (ILD) Product Offerings
Table 32. Boehringer Ingelheim Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 33. Bellerophon Therapeutics, Inc Corporate Summary
Table 34. Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Product Offerings
Table 35. Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Interstitial Lung Disease (ILD) Product Offerings
Table 38. Bayer Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 39. Fujirebio (Miraca) Corporate Summary
Table 40. Fujirebio (Miraca) Interstitial Lung Disease (ILD) Product Offerings
Table 41. Fujirebio (Miraca) Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 42. Philips Corporate Summary
Table 43. Philips Interstitial Lung Disease (ILD) Product Offerings
Table 44. Philips Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Interstitial Lung Disease (ILD) Product Offerings
Table 47. Merck Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 48. Siemens Healthineers Corporate Summary
Table 49. Siemens Healthineers Interstitial Lung Disease (ILD) Product Offerings
Table 50. Siemens Healthineers Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 1. Interstitial Lung Disease (ILD) Market Opportunities & Trends in Global Market
Table 2. Interstitial Lung Disease (ILD) Market Drivers in Global Market
Table 3. Interstitial Lung Disease (ILD) Market Restraints in Global Market
Table 4. Key Players of Interstitial Lung Disease (ILD) in Global Market
Table 5. Top Interstitial Lung Disease (ILD) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Interstitial Lung Disease (ILD) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Interstitial Lung Disease (ILD) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Interstitial Lung Disease (ILD) Product Type
Table 9. List of Global Tier 1 Interstitial Lung Disease (ILD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Interstitial Lung Disease (ILD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Interstitial Lung Disease (ILD) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Interstitial Lung Disease (ILD) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Interstitial Lung Disease (ILD) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Interstitial Lung Disease (ILD) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Interstitial Lung Disease (ILD) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Interstitial Lung Disease (ILD) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2023-2028
Table 30. Boehringer Ingelheim Corporate Summary
Table 31. Boehringer Ingelheim Interstitial Lung Disease (ILD) Product Offerings
Table 32. Boehringer Ingelheim Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 33. Bellerophon Therapeutics, Inc Corporate Summary
Table 34. Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Product Offerings
Table 35. Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Interstitial Lung Disease (ILD) Product Offerings
Table 38. Bayer Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 39. Fujirebio (Miraca) Corporate Summary
Table 40. Fujirebio (Miraca) Interstitial Lung Disease (ILD) Product Offerings
Table 41. Fujirebio (Miraca) Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 42. Philips Corporate Summary
Table 43. Philips Interstitial Lung Disease (ILD) Product Offerings
Table 44. Philips Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Interstitial Lung Disease (ILD) Product Offerings
Table 47. Merck Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
Table 48. Siemens Healthineers Corporate Summary
Table 49. Siemens Healthineers Interstitial Lung Disease (ILD) Product Offerings
Table 50. Siemens Healthineers Interstitial Lung Disease (ILD) Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Interstitial Lung Disease (ILD) Segment by Type in 2021
Figure 2. Interstitial Lung Disease (ILD) Segment by Application in 2021
Figure 3. Global Interstitial Lung Disease (ILD) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Interstitial Lung Disease (ILD) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Interstitial Lung Disease (ILD) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Interstitial Lung Disease (ILD) Revenue in 2021
Figure 8. By Type - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 12. US Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 16. Germany Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 17. France Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 24. China Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 28. India Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 30. Brazil Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 33. Turkey Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 37. Boehringer Ingelheim Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Fujirebio (Miraca) Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Philips Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Siemens Healthineers Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Interstitial Lung Disease (ILD) Segment by Type in 2021
Figure 2. Interstitial Lung Disease (ILD) Segment by Application in 2021
Figure 3. Global Interstitial Lung Disease (ILD) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Interstitial Lung Disease (ILD) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Interstitial Lung Disease (ILD) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Interstitial Lung Disease (ILD) Revenue in 2021
Figure 8. By Type - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 12. US Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 16. Germany Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 17. France Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 24. China Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 28. India Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 30. Brazil Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Interstitial Lung Disease (ILD) Revenue Market Share, 2017-2028
Figure 33. Turkey Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Interstitial Lung Disease (ILD) Revenue, (US$, Mn), 2017-2028
Figure 37. Boehringer Ingelheim Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Fujirebio (Miraca) Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Philips Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Siemens Healthineers Interstitial Lung Disease (ILD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
